The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech Covid-19 vaccine on children aged 12 to 15 years old.
Acting FDA commissioner Janet Woodcock described the move as a ‘significant step in the fight against the Covid-19 pandemic.’
‘Today's action allows for a younger population to be protected from Covid-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,’ Woodcock said in a statement.
‘Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our Covid-19 vaccine emergency use authorizations,’ she added.
The FDA previously granted an emergency use authorization for the Pfizer-BioNTech vaccine to individuals aged 16 and older.
‘Having a vaccine authorized for a younger population is a critical step in continuing to lessen the immense public health burden caused by the Covid-19 pandemic,’ said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
The FDA said some 1.5 million Covid-19 cases in individuals aged 11 to 17 years old have been reported to the Centers for Disease Control and Prevention between March 1, 2020 through April 30, 2021.
The course of the disease is generally milder in children but they can pass it on to older, more vulnerable adults.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Fifth presidential hopeful arrested in Nicaragua
Navalny poisoning: US preparing new Russia sanctions
Blanchett sees pandemic as chance for reflection on plight of refugees
Cheers, quiet reflection from American crowds marking Juneteenth
Bidens mourn the passing of ‘first dog’
'Apocalyptic' heat wave scorches US Southwest again
US sees ‘summer of joy’ as Covid shots surpass 300mn
Largest Boeing 737 Max model set for maiden flight
US suspects 4,000 cases of fraud in Iraqi refugee program: documents